$ Value
$0
Shares
2,967
Price
$0
Filed
Jun 17
Insider
Name
Tezel Ahmet
Title
Chief Innovation Officer
CIK
0002023439
Roles
Transaction Details
Transaction Date
2025-06-15
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,967
Footnotes
Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. | Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement. | Shares withheld to satisfy tax liability. | On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
Filing Info
Tezel Ahmet's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-30 | LIVN | M | $0 |
| 2026-03-30 | LIVN | F | $73K |
| 2026-03-30 | LIVN | M | $0 |
| 2026-03-30 | LIVN | A | $0 |
| 2026-03-30 | LIVN | A | $0 |
| 2026-03-30 | LIVN | A | $0 |
| 2026-03-30 | LIVN | A | $0 |
| 2025-06-15 | LIVN | M | $0 |
| 2025-06-15 | LIVN | F | $47K |
| 2025-06-15 | LIVN | M | $0 |
Other Insiders at LIVN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Shvartsburg Alex
Chief Financial Officer
|
— | — | 2026-03-30 |
|
Bolton Stephanie
President, Global Epilepsy
|
— | — | 2026-03-30 |
|
Makatsaria Vladimir
Chief Executive Officer
|
— | — | 2026-03-30 |
|
Tezel Ahmet
Chief Innovation Officer
|
— | — | 2026-03-30 |
|
Poletti Franco
President, Cardiopulmonary
|
— | — | 2026-03-30 |
|
Kozmina Natalia
Chief Human Resources Officer
|
— | — | 2026-03-30 |